Phathom Pharmaceuticals Inc.
PHAT | NASDAQ
$7.45
-$0.03 (-0.40%)
At close: Sep 21, 2026, 4:00 PM ET
$7.45
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $605.14M
Enterprise Value $422.76M
Beta 0.51
Average Volume 1.3M
Shares Outstanding (Diluted) 83.75M
Shares Change YoY 15.57%
Institutional Ownership 83.96%
Exchange NASDAQ
ISIN US71722W1071
Price Performance
Price Change 1M -16.1%
Price Change 3M -31.4%
Price Change 6M -28.8%
Price Change YTD -52.6%
Price Change 1Y -36.5%
Price Change 3Y -29.9%
Price Change 5Y -76.6%
1M CAGR (ann.) -10.8%
1Y CAGR (ann.) -32.0%
5Y CAGR (ann.) -25.9%
All-Time CAGR -15.8%
Valuation
PE Ratio -5.82
Forward PE 10.61
PEG Ratio -0.04
Forward PEG 0.03
PS Ratio 2.51
Forward PS 1.20
PB Ratio -1.75
P/FCF Ratio -16.49
P/Adj. FCF Ratio -9.46
P/OCF Ratio -16.93
EV/Sales 1.76
EV/EBIT -12.75
EV/EBITDA -11.51
EV/FCF -11.57
Earnings Yield -17.2%
FCF Yield -6.1%
Adj. FCF Yield -10.6%
Financial Health
Net Cash $179.95M
Total Debt $2.53M
Cash & Short-Term Investments $182.48M
Total Assets $327.08M
Current Ratio 1.92
Quick Ratio 1.87
Debt / Equity Ratio -0.49
Debt / EBITDA -0.07
Debt / FCF -0.07
OCF / Debt -14.53
Interest Coverage -0.64
Altman Z-Score -5.10
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 82.9%
Operating Profit Margin -17.0%
EBITDA Margin -14.7%
Net Profit Margin -41.3%
FCF Margin -15.3%
Adj. FCF Margin -26.6%
SBC / Revenue 11.3%
SBC Impact (per share) -74.3%
Returns
Return on Assets -30.3%
Return on Equity 25.7%
Return on Invested Capital -23.4%
Return on Capital Employed -23.4%
Return on Tangible Assets -30.3%
Historical Growth (CAGR)
Revenue CAGR 3Y 94.8%
Revenue CAGR 5Y 81.6%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 51.8%
EPS CAGR 5Y 15.5%
EPS CAGR 10Y N/A
FCF CAGR 3Y 51.2%
FCF CAGR 5Y 4.6%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 9
EPS Growth Next 3Y 117.7%
Revenue Growth Next 3Y 51.9%
Earnings Date Oct 28, 2026
EPS Estimate (next Q) $0.07
EPS Growth Est (next Q) -117.1%
Revenue Est (next Q) $85.38M
Revenue Growth Est (next Q) 72.5%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $17.60
Price Target Upside 136.2%
Cash Flow
Operating Cash Flow $-36.69M
Free Cash Flow $-36.54M
Adj. Free Cash Flow $-63.7M
FCF Per Share -$0.44
OCF Per Share -$0.44
OCF/S Ratio -15.3%
Income Statement
Revenue $239.66M
Gross Profit $198.73M
Operating Income $-40.64M
EBITDA $-36.74M
Net Income $-81.49M
EPS (Diluted) -$1.28
Revenue / Employee $645.99K
Profit / Employee $-219.65K
Employees 371
Add to Watchlist
Select watchlists to add or remove PHAT